Navigation Links
Agrenco Informs Sale of Biodiesel at ANP Auction
Date:4/11/2008

SAO PAULO, April 11 /PRNewswire-FirstCall/ -- Agrenco Ltd. (Bovespa: AGEN11), one of the largest provider of integrated and customized solutions for agribusiness, with global operations, hereby announces to its shareholders and investors that, on April 10, 2008, the National Petroleum Agency (ANP) held an auction for the acquisition of 264,000 m3 of biodiesel, for delivery between July 1 and September 30, 2008. The purpose of the auction was to ensure supply of the necessary volumes for the mandatory blend of 3% of biodiesel in all mineral diesel oil consumed in Brazil, which will be in force as from July 1, 2008.

Agrenco Bioenergia sold a total of 39,600 m3 of ANP-standard biodiesel, which represents 15% of the auction total volume, at the average price of R$ 2,465.0/m3 -- price does not include ICMS (value-added tax on services and goods). All biodiesel will be produced in the newly opened Alto Araguaia Industrial Complex (Mato Grosso state) with deliveries scheduled between July 1 and September 30, 2008. The acquiring federal body will be responsible for take up of deliveries of the biodiesel at the Alto Araguaia Industrial Complex. Total revenues from the biofuel sale will amount to approximately R$ 98 million.

This sale represents the entrance of the Agrenco Group into the Brazilian biodiesel market, the Company's milestone towards consolidating its brand in the bioenergy sector, and the first major supply from the Alto Araguaia Industrial Complex. The purchase and sale agreement will be entered into within 10 days as of the publication by ANP in the "Diario Oficial".
For further information contact Agrenco's Investor Relations Team:

Investor Relations

Marco Antonio de Modesti

IR Manager

Phone.: +55 (11) 3572-0137

E-mail: ri@agrenco.com.br

Website: http://www.agrencogroup.com/ri


'/>"/>
SOURCE Agrenco Ltd.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. New Benefuel Refinery Targets Key Flaws in Biodiesel Production
2. FreshDirects Fleet Goes Biodiesel
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... March 22, 2017  Personal Genome Diagnostics Inc. ... testing contract with the U.S. Department of Veterans ... assay with the company,s new CancerSELECT ™ ... actionable pan-cancer profiling test that includes microsatellite instability ... patient response to checkpoint inhibitor immunotherapies. CancerSELECT 125 ...
(Date:3/22/2017)... FRANCISCO , March 22, 2017   ... fastest growing genetic information companies, today announced the ... diagnosis of Spinal Muscular Atrophy (SMA) , ... leading lethal genetic disorders among infants as well ... in childhood. The new test, announced during the ...
(Date:3/20/2017)... , ... March 20, 2017 ... ... that interfere with the ability of endogenous hormones to regulate homeostasis via ... binding activity (antagonists), EDCs produce adverse reproductive, neurological, proliferative, and immunological disorders. ...
(Date:3/20/2017)... ... March 20, 2017 , ... ... (GI) disorders, today announced that it has entered into an exclusive global license ... inflammatory bowel disease including Necrotizing Enterocolitis (rare orphan disease) as well as Crohn’s ...
Breaking Biology Technology:
(Date:2/21/2017)... and PORTLAND, Ore. , Feb. ... the Avamere Family of Companies (Avamere Health Services, Infinity ... a six-month research study that will apply the power ... at senior living and health centers. By analyzing data ... to gain insights into physical and environmental conditions, and ...
(Date:2/14/2017)... 14, 2017  Wake Forest Baptist Medical Center today ... chief executive officer (CEO). Freischlag joins the medical center ... McConnell , M.D., who last year announced that he ... Center, after leading it since 2008.   ... Wake Forest Baptist,s academic health system, which includes Wake ...
(Date:2/10/2017)... 2017 Research and Markets has ... Medicine - Scientific and Commercial Aspects" to their offering. ... ... integrated with therapy for selection of treatment as well for ... prevention of disease in modern medicine. Biochip/microarray technologies and next ...
Breaking Biology News(10 mins):